Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr744 Inhibitors

Olr744 inhibitors represent a fascinating class of chemical compounds characterized by their ability to selectively interact with the olfactory receptor Olr744. These receptors are part of the large family of G protein-coupled receptors (GPCRs), which play a crucial role in the sensory perception of odors. Structurally, Olr744 inhibitors often contain specific moieties that allow them to bind with high affinity to the receptor's binding site. This interaction typically involves a combination of hydrogen bonding, hydrophobic interactions, and Van der Waals forces, ensuring a stable and specific binding. The binding affinity and specificity are often a result of meticulous structure-activity relationship (SAR) studies, which help in identifying the most potent chemical structures. These inhibitors can be synthetically derived through various organic synthesis pathways, often involving multiple steps of reaction sequences such as alkylation, acylation, and cyclization, to construct the desired molecular framework.

Chemically, Olr744 inhibitors can exhibit a wide range of physicochemical properties depending on their molecular architecture. They may vary in terms of solubility, stability, and molecular weight, all of which are critical parameters influencing their interaction with the olfactory receptor. Advanced techniques such as X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy are often employed to elucidate the precise binding conformation of these inhibitors within the receptor site. Additionally, computational modeling and molecular docking studies provide insights into the dynamic behavior of the inhibitor-receptor complex. The ability to finely tune these interactions allows researchers to design inhibitors with optimal binding characteristics, paving the way for a deeper understanding of olfactory signal transduction mechanisms. These studies contribute significantly to the broader field of chemical biology, enhancing our knowledge of GPCR functions and the intricate processes governing olfactory perception.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

Inhibits RAF kinase, potentially affecting proteins in RAF/MEK/ERK signaling pathways.

XL-184 free base

849217-68-1sc-364657
sc-364657A
5 mg
10 mg
$94.00
$208.00
1
(1)

MET, VEGFR2, and RET inhibitor, potentially disrupting proteins in associated signaling pathways.

Temozolomide

85622-93-1sc-203292
sc-203292A
25 mg
100 mg
$91.00
$255.00
32
(1)

Alkylating agent, potentially disrupting DNA repair and affecting associated protein pathways.

AP 24534

943319-70-8sc-362710
sc-362710A
10 mg
50 mg
$175.00
$983.00
2
(1)

BCR-ABL and FLT3 inhibitor, potentially affecting proteins in leukemia signaling pathways.

Osimertinib

1421373-65-0sc-507355
5 mg
$86.00
(0)

EGFR inhibitor, potentially affecting proteins in EGFR signaling pathways.

CH5424802

1256580-46-7sc-364461
sc-364461A
5 mg
50 mg
$191.00
$902.00
(0)

ALK inhibitor, potentially impacting proteins in associated signaling pathways.

Ribociclib

1211441-98-3sc-507367
10 mg
$450.00
(0)

CDK4/6 inhibitor, potentially affecting proteins involved in cell cycle regulation.

Cobimetinib

934660-93-2sc-507421
5 mg
$270.00
(0)

MEK inhibitor, potentially affecting proteins in the MAPK/ERK pathway.

Abemaciclib

1231929-97-7sc-507342
10 mg
$110.00
(0)

CDK4/6 inhibitor, potentially disrupting proteins involved in cell cycle regulation.

Belinostat

414864-00-9sc-269851
sc-269851A
10 mg
100 mg
$156.00
$572.00
(1)

HDAC inhibitor, potentially affecting gene expression and associated protein pathways.